ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | Predicted membrane proteins Transporters
| | | | | Mixed |
ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ADCY3 | Adenylate cyclase 3 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP10D | ATPase, class V, type 10D | Enzymes Predicted membrane proteins
| | | | | Mixed |
ATP11A | ATPase, class VI, type 11A | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP9A | ATPase, class II, type 9A | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
CLCN7 | Chloride channel, voltage-sensitive 7 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
DHCR7 | 7-dehydrocholesterol reductase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
KIAA0195 | KIAA0195 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MFSD11 | Major facilitator superfamily domain containing 11 | Predicted membrane proteins
| | | | | Expressed in all |
MFSD2A | Major facilitator superfamily domain containing 2A | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
MT-CO1 | Mitochondrially encoded cytochrome c oxidase I | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
NNT | Nicotinamide nucleotide transhydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
PIGN | Phosphatidylinositol glycan anchor biosynthesis, class N | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
SLC12A8 | Solute carrier family 12, member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC15A3 | Solute carrier family 15 (oligopeptide transporter), member 3 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC15A4 | Solute carrier family 15 (oligopeptide transporter), member 4 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC16A1 | Solute carrier family 16 (monocarboxylate transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC16A3 | Solute carrier family 16 (monocarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC17A5 | Solute carrier family 17 (acidic sugar transporter), member 5 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
SLC18B1 | Solute carrier family 18, subfamily B, member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC29A1 | Solute carrier family 29 (equilibrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC29A4 | Solute carrier family 29 (equilibrative nucleoside transporter), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A10 | Solute carrier family 2 (facilitated glucose transporter), member 10 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SLC30A5 | Solute carrier family 30 (zinc transporter), member 5 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35B3 | Solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35C1 | Solute carrier family 35 (GDP-fucose transporter), member C1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35E1 | Solute carrier family 35, member E1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC38A10 | Solute carrier family 38, member 10 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC41A3 | Solute carrier family 41, member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC46A1 | Solute carrier family 46 (folate transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC4A7 | Solute carrier family 4, sodium bicarbonate cotransporter, member 7 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC7A5 | Solute carrier family 7 (amino acid transporter light chain, L system), member 5 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC9A1 | Solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC9A6 | Solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
STT3B | STT3B, subunit of the oligosaccharyltransferase complex (catalytic) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
SV2C | Synaptic vesicle glycoprotein 2C | Predicted membrane proteins
| | | | | Tissue enhanced |